These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18990330)

  • 41. [Myopathy with rhabdomyolysis as an adverse effect of simultaneous treatment with cerivastatin and gemfibrozil].
    Huić M; Anić B; Cikes N; Bosnić D; Sentić M; Markeljević J; Mayer M; Pazanin L
    Lijec Vjesn; 2002; 124(3-4):73-6. PubMed ID: 18956824
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic cough as a complication of treatment with statins: a case report.
    Psaila M; Fsadni P; Montefort S
    Ther Adv Respir Dis; 2012 Aug; 6(4):243-6. PubMed ID: 22761129
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Steady-state pharmacokinetics of fluvastatin in healthy subjects following a new extended release fluvastatin tablet, Lescol XL.
    Barilla D; Prasad P; Hubert M; Gumbhir-Shah K
    Biopharm Drug Dispos; 2004 Mar; 25(2):51-9. PubMed ID: 14872552
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Myotoxicity and rhabdomyolisis due to statins].
    Banga JD
    Ned Tijdschr Geneeskd; 2001 Dec; 145(49):2371-6. PubMed ID: 11770264
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potential interaction between warfarin and fluvastatin.
    Trilli LE; Kelley CL; Aspinall SL; Kroner BA
    Ann Pharmacother; 1996 Dec; 30(12):1399-402. PubMed ID: 8968451
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized statin trials.
    Alsheikh-Ali AA; Maddukuri PV; Han H; Karas RH
    J Am Coll Cardiol; 2007 Jul; 50(5):409-18. PubMed ID: 17662392
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Marked elevation of liver transaminases after high-dose fluvastatin unmasks chronic hepatitis C: safety and re-challenge.
    Chen YW; Lai HW; Wang TD
    Acta Neurol Taiwan; 2007 Sep; 16(3):163-7. PubMed ID: 17966956
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statins.
    Stein EA; Ballantyne CM; Windler E; Sirnes PA; Sussekov A; Yigit Z; Seper C; Gimpelewicz CR
    Am J Cardiol; 2008 Feb; 101(4):490-6. PubMed ID: 18312764
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical inquiries. Do statins cause myopathy?
    Daugird AJ; Crowell K; Saseen J
    J Fam Pract; 2003 Dec; 52(12):973-7. PubMed ID: 14653986
    [No Abstract]   [Full Text] [Related]  

  • 50. Is decreased libido associated with the use of HMG-CoA-reductase inhibitors?
    de Graaf L; Brouwers AH; Diemont WL
    Br J Clin Pharmacol; 2004 Sep; 58(3):326-8. PubMed ID: 15327593
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor fluvastatin in hyperlipidemic patients treated with probucol.
    Sasaki S; Nakagawa M; Nakata T; Endo N; Miyao K; Kitamura K; Fukuyama M; Kitani T; Yamada C
    Cardiology; 1997; 88(2):160-5. PubMed ID: 9096917
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fluvastatin and perioperative events in patients undergoing vascular surgery.
    Schouten O; Boersma E; Hoeks SE; Benner R; van Urk H; van Sambeek MR; Verhagen HJ; Khan NA; Dunkelgrun M; Bax JJ; Poldermans D;
    N Engl J Med; 2009 Sep; 361(10):980-9. PubMed ID: 19726772
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Statin induced myotoxicity: the lactone forms are more potent than the acid forms in human skeletal muscle cells in vitro.
    Skottheim IB; Gedde-Dahl A; Hejazifar S; Hoel K; Asberg A
    Eur J Pharm Sci; 2008 Apr; 33(4-5):317-25. PubMed ID: 18294823
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [High dose of simvastatin to minimize the risk of myopathy?].
    Frey O
    Med Monatsschr Pharm; 2010 Sep; 33(9):354-5. PubMed ID: 21192445
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
    Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Statin-induced myopathy.
    Gounden R; Blockman M
    Cardiovasc J Afr; 2008; 19(3):156-7. PubMed ID: 18568178
    [No Abstract]   [Full Text] [Related]  

  • 57. Efficacy and safety of once-daily vs twice-daily dosing with fluvastatin, a synthetic reductase inhibitor, in primary hypercholesterolemia.
    Insull W; Black D; Dujovne C; Hosking JD; Hunninghake D; Keilson L; Knopp R; McKenney J; Stein E; Troendle AJ
    Arch Intern Med; 1994 Nov; 154(21):2449-55. PubMed ID: 7979841
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Statins and hepatitis C virus: friend or foe?
    Emanuele E
    Hepatology; 2010 Jan; 51(1):352. PubMed ID: 19603497
    [No Abstract]   [Full Text] [Related]  

  • 59. Letter by Rosenberg and Uretsky regarding article, "Risks associated with statin therapy: a systematic overview of randomized clinical trials".
    Rosenberg L; Uretsky S
    Circulation; 2007 Jul; 116(1):e8; author reply e9. PubMed ID: 17606852
    [No Abstract]   [Full Text] [Related]  

  • 60. Efficacy and safety of fluvastatin in hypertensive patients. An analysis of a clinical trial database.
    Peters TK; Mehra M; Muratti EN
    Am J Hypertens; 1993 Nov; 6(11 Pt 2):340S-345S. PubMed ID: 8297542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.